PHARMACEUTICAL RAW MATERIALS AND EXCIPIENTS OPTIONS

“The existing circumstance has exposed some structural weaknesses in the EU’s medicines offer chain and also a higher dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides claimed. She proposed that offer chain issues be tackled within an EU pharmaceutical approach envisioned for being launched by the top of the ca